
Multi-cancer early detection testing market to reach $7.52b by 2033
By end-user, hospitals and clinics accounted for $950m in 2024.
The multi-cancer early detection testing market is expected to reach $7.52b by 2033 at a compound annual growth rate of 16.5%, said DataM Intelligence.
The sector’s expansion is attributed to the use of precision diagnostics and liquid biopsy technologies.
By end-user, hospitals and clinics accounted for $950m in 2024.
By cancer type, breast cancer dominated the market in 2024 with a value of $420M, supported by early detection initiatives in the US and Japan.